Big Gain For Affimed N.V.
Mon, Jun 03, 2024 at 07:20 PM
Affimed N.V. (AFMD:NASDAQ) soared at $7.33, representing a gain of 68.5%. On Mon, Jun 03, 2024, AFMD:NASDAQ hit a New 2-Week High of $7.33. The stock got featured on our News Catalysts scanner on Mon, Jun 03, 2024 at 05:24 PM in the 'BIOTECH' category. From Mon, May 20, 2024, the stock recorded 33.33% Up Days and 30.00% Green Days
About Affimed N.V. (AFMD:NASDAQ)
Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology to fight tumor cells.
Top 10 Gainers:
- Avalon GloboCare Corp. (ALBT:NASDAQ), 316.95%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 100%
- Hywin Holdings Ltd. (HYW:NASDAQ), 91.19%
- Affimed N.V. (AFMD:NASDAQ), 68.51%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 61.29%
- Concord Medical Services Holdings Limited (CCM:NYSE), 57.99%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 56.8%
- Structure Therapeutics Inc. (GPCR:NASDAQ), 54.21%
- Histogen Inc. (HSTO:NASDAQ), 45.35%
- Power REIT (PW:NYSEMKT), 39.1%